Low energy availability surrogates correlate with health and performance consequences of Relative Energy Deficiency in Sport.


Journal

British journal of sports medicine
ISSN: 1473-0480
Titre abrégé: Br J Sports Med
Pays: England
ID NLM: 0432520

Informations de publication

Date de publication:
May 2019
Historique:
accepted: 16 05 2018
pubmed: 4 6 2018
medline: 4 6 2019
entrez: 4 6 2018
Statut: ppublish

Résumé

Low energy availability (EA) is suspected to be the underlying cause of both the Female Athlete Triad and the more recently defined syndrome, Relative Energy Deficiency in Sport (RED-S). The International Olympic Committee (IOC) defined RED-S as a syndrome of health and performance impairments resulting from an energy deficit. While the importance of adequate EA is generally accepted, few studies have attempted to understand whether low EA is associated with the health and performance consequences posited by the IOC. The purpose of this cross-sectional study was to examine the association of low EA with RED-S health and performance consequences in a large clinical population of female athletes. One thousand female athletes (15-30 years) completed an online questionnaire and were classified as having low or adequate EA. The associations between low EA and the health and performance factors listed in the RED-S models were evaluated using chi-squared test and the odds ratios were evaluated using binomial logistic regression (p<0.05). Athletes with low EA were more likely to be classified as having increased risk of menstrual dysfunction, poor bone health, metabolic issues, haematological detriments, psychological disorders, cardiovascular impairment and gastrointestinal dysfunction than those with adequate EA. Performance variables associated with low EA included decreased training response, impaired judgement, decreased coordination, decreased concentration, irritability, depression and decreased endurance performance. These findings demonstrate that low EA measured using self-report questionnaires is strongly associated with many health and performance consequences proposed by the RED-S models.

Identifiants

pubmed: 29860237
pii: bjsports-2017-098958
doi: 10.1136/bjsports-2017-098958
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

628-633

Informations de copyright

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Kathryn E Ackerman (KE)

Female Athlete Program, Division of Sports Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Neuroendocrine Unit, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.

Bryan Holtzman (B)

Female Athlete Program, Division of Sports Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.

Katherine M Cooper (KM)

Female Athlete Program, Division of Sports Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.

Erin F Flynn (EF)

Female Athlete Program, Division of Sports Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.

Georgie Bruinvels (G)

UCL Division of Surgery and Interventional Science, University College London, London, UK.
Orreco Ltd, National University of Ireland Business Innovation Centre, Galway, Ireland.

Adam S Tenforde (AS)

Department of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Rehabilitation Hospital, Boston, Massachusetts, USA.

Kristin L Popp (KL)

Division of Endocrinology, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.

Andrew J Simpkin (AJ)

Orreco Ltd, National University of Ireland Business Innovation Centre, Galway, Ireland.
Insight Centre for Data Analytics, National University of Ireland, Galway, Ireland.

Allyson L Parziale (AL)

Female Athlete Program, Division of Sports Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH